Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Tumbles 40 Points. More details...
CBT 200 Climbs 2%. More details...
Company Seeks $324 Million Market Cap. More details...
CBT 200 Climbs 4%. More details...
CBT 200 Rises 16 Points. More details...
Blockbuster Drug Extends Its Reach. More details...
CBT 200 Little Changed With 12 Point Rise. More details...
Exclusive Right To GeneMap of Complex Disease. More...
CBT 200 Off By 7 Points. More details...
CBT 200 Falls Another 22 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China